A detailed history of Parallax Volatility Advisers, L.P. transactions in Argenx Se stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 10,300 shares of ARGX stock, worth $6.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,300
Previous 18,800 45.21%
Holding current value
$6.47 Million
Previous $8.08 Million 30.9%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $338,031 - $391,385
-947 Reduced 29.49%
2,264 $891,000
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $1.09 Million - $1.62 Million
3,211 New
3,211 $1.22 Million
Q4 2020

Feb 16, 2021

SELL
$248.13 - $308.36 $38,956 - $48,412
-157 Reduced 31.09%
348 $102,000
Q3 2020

Nov 13, 2020

BUY
$215.51 - $272.51 $108,832 - $137,617
505 New
505 $133,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.